Sector
HealthcareCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹2,102.2Prev. Close
₹2,093.9Turnover(Lac.)
₹562.07Day's High
₹2,135Day's Low
₹2,101.0552 Week's High
₹2,356.452 Week's Low
₹1,720Book Value
₹233.19Face Value
₹10Mkt Cap (₹ Cr.)
16,983.1P/E
72.13EPS
29.41Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 80.03 | 80.03 | 77.59 | 74.8 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,550.83 | 1,297.52 | 829.73 | 549.33 |
Net Worth | 1,630.86 | 1,377.55 | 907.32 | 624.13 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Revenue | 1,143.37 | 932.68 |
yoy growth (%) | 22.58 | |
Raw materials | -249.9 | -201.19 |
As % of sales | 21.85 | 21.57 |
Employee costs | -174.02 | -147.03 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Profit before tax | 371 | 254.26 |
Depreciation | -44.92 | -44.59 |
Tax paid | -92.63 | -65.61 |
Working capital | -27.52 | |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | 22.58 | |
Op profit growth | 30.32 | |
EBIT growth | 39.55 | |
Net profit growth | 47.55 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 2,498.14 | 2,197.68 | 1,650.83 | 1,329.94 | 1,122.65 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,498.14 | 2,197.68 | 1,650.83 | 1,329.94 | 1,122.65 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 13.06 | 40.7 | 29.77 | 10.17 | 6.08 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 916.4 | 129.02 | 88,657.85 | 241.77 | 0.16 | 610.11 | 79.02 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,142.9 | 86.8 | 87,717.27 | 238.8 | 0.1 | 1,894.6 | 536.28 |
Fortis Healthcare Ltd FORTIS | 471.25 | 279.66 | 34,626.16 | 68.33 | 0.22 | 307.48 | 120.36 |
Global Health Ltd MEDANTA | 1,277.35 | 94.84 | 34,226.64 | 92.24 | 0 | 578.65 | 106.09 |
Narayana Hrudayalaya Ltd NH | 1,230.95 | 58.86 | 24,984.13 | 158.09 | 0.33 | 846.31 | 90.04 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director
Bhaskara Rao Bollineni
Executive Director & CEO
Abhinay Bollineni
WTD & Executive Director
Dandamudi Anitha
Independent Non Exe. Director
Rajeswara Rao Gandu
Independent Non Exe. Director
Saumen Chakraborty
Independent Non Exe. Director
Pankaj Vaish
Independent Non Exe. Director
Ratna Kishore Kaza
Independent Non Exe. Director
J V Ramudu
Independent Non Exe. Director
Y Prameela Rani
Non Executive Director
Shantanu Rastogi
Independent Director
Y Prameela Rani
Additional Director
Adwik Bollineni
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Krishna Institute of Medical Sciences Ltd
Summary
Krishna Institute of Medical Sciences Limited (KIMS) was incorporated as Jagjit Singh and Sons Private Limited, a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, name of the Company was changed to Krishna Institute of Medical Sciences Private Limited on January 2, 2004. Pursuant to the conversion of Company to a Public Limited Company, the name was changed to Krishna Institute of Medical Sciences Limited on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It operate 12 multispecialty hospitals under the KIMS Hospitals brand, with an aggregate capacity of over 4,000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care.Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company.Led by Dr. Bhas
Read More
The Krishna Institute of Medical Sciences Ltd shares price on nse is Rs.₹2122.15 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Krishna Institute of Medical Sciences Ltd is ₹16983.10 Cr. as of 03 Jul ‘24
The PE and PB ratios of Krishna Institute of Medical Sciences Ltd is 72.13 and 9.10 as of 03 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Krishna Institute of Medical Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Krishna Institute of Medical Sciences Ltd is ₹1720 and ₹2356.4 as of 03 Jul ‘24
Krishna Institute of Medical Sciences Ltd's CAGR for 5 Years at 16.00%, 3 Years at 27.16%, 1 Year at 19.22%, 6 Month at 7.73%, 3 Month at 0.90% and 1 Month at 14.24%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.